These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3036426)
41. Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. Esscher T; Steinholtz L; Bergh J; Nöu E; Nilsson K; Påhlman S Thorax; 1985 Feb; 40(2):85-90. PubMed ID: 2983452 [TBL] [Abstract][Full Text] [Related]
42. [Determination of tumor markers NSE and CEA in patients with various lung diseases, especially carcinomas]. Velcovsky HG; Hofmann H; Discher T; Laumen R; Jungbluth H Immun Infekt; 1986 Feb; 14(1):32-4. PubMed ID: 3957406 [TBL] [Abstract][Full Text] [Related]
43. [The "neuron-specific enolase" tumor marker as a prognostic indicator in small cell bronchial carcinoma]. Hoster M; Kirchheiner T; Rühle KH Pneumologie; 1995 Aug; 49(8):470-4. PubMed ID: 7479642 [TBL] [Abstract][Full Text] [Related]
44. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging. Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667 [TBL] [Abstract][Full Text] [Related]
45. Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma. Sarandakou A; Poulakis N; Rizos D; Trakakis E; Phocas I Anticancer Res; 1993; 13(1):173-5. PubMed ID: 8386493 [TBL] [Abstract][Full Text] [Related]
46. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Schneider J; Philipp M; Salewski L; Velcovsky HG Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474 [TBL] [Abstract][Full Text] [Related]
47. [The value of determining neuron specific enolase for diagnosis of complete remission during treatment of small cell lung cancer]. Rowińska-Zakrzewska E; Szturmowicz M; Wiatr E; Sakowicz A; Pawlicka L; Remiszewski P; Szopiński J; Zych J; Radzikowska E Pneumonol Alergol Pol; 1996; 64(1-2):19-23. PubMed ID: 8630460 [TBL] [Abstract][Full Text] [Related]
48. Brain-specific proteins: solid-phase immunobioluminescence assay for neuron-specific enolase in human plasma. Gerbitz KD; Summer J; Thallemer J Clin Chem; 1984 Mar; 30(3):382-6. PubMed ID: 6321057 [TBL] [Abstract][Full Text] [Related]
49. Rapid electrophoretic determination of neuron-specific enolase isoenzymes in serum. Viallard JL; Ven Murthy MR; Dastugue B Clin Chem; 1986 Apr; 32(4):593-7. PubMed ID: 3006942 [TBL] [Abstract][Full Text] [Related]
50. Atypical enolase isoenzyme in serum: a macroenolase formed from the alpha gamma-hybrid form. Viallard JL; Caillaud D; Kantelip B Clin Chem; 1990 Nov; 36(11):2000-3. PubMed ID: 2242594 [TBL] [Abstract][Full Text] [Related]
51. [Prognostic value of serum neurospecific enolase in small cell bronchial carcinoma]. Romero Candeira S; Hernández Blasco L; Martín Serrano C; Pérez Carbonell A Med Clin (Barc); 1993 Oct; 101(10):399. PubMed ID: 8231352 [No Abstract] [Full Text] [Related]
52. Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer. Cuomo A; Capra R; Greco S; Cacciani GC; Greco F; Franchini D; Bonelli P; Gavaruzzi G; Ugolotti G Acta Biomed Ateneo Parmense; 1993; 64(5-6):171-84. PubMed ID: 7992555 [No Abstract] [Full Text] [Related]
53. Beta-enolase in blood plasma during open heart surgery. Usui A; Kato K; Abe T; Murase M; Tanaka M; Takeuchi E Cardiovasc Res; 1989 Sep; 23(9):737-40. PubMed ID: 2514995 [TBL] [Abstract][Full Text] [Related]
54. [Neuron-specific enolase as a tumor marker]. Biran H Harefuah; 1994 Dec; 127(11):500-2. PubMed ID: 7806116 [No Abstract] [Full Text] [Related]
55. [Neuron specific enolase in small cell lung cancer]. Lee HJ; Chiang CD; Yiih KT; Huang WL; Jih KS; Lin TM; Chung WC; Sheu JY; Wang SJ Taiwan Yi Xue Hui Za Zhi; 1988 Apr; 87(4):465-71. PubMed ID: 2852705 [No Abstract] [Full Text] [Related]
56. [Clinical significance of serum NSE assay as a tumor marker]. Ariyoshi Y; Kuwabara M Nihon Rinsho; 1990 Feb; 48 Suppl():1035-7. PubMed ID: 2162410 [No Abstract] [Full Text] [Related]
57. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer. Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of Cyfra 21-1 as a marker for lung cancer. Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188 [TBL] [Abstract][Full Text] [Related]
59. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase. Giovanella L; Ceriani L; Bandera M; Garancini S Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956 [TBL] [Abstract][Full Text] [Related]
60. [Neuron-specific enolase--a selective marker of small cell bronchial cancer]. Lorenz J; Mai GA; Schulz V Prax Klin Pneumol; 1986 Mar; 40(3):100-2. PubMed ID: 3012500 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]